Gordon Ng is a partner in Dentons' Hong Kong office and the head of the Corporate Finance practice in Asia.
Gordon's practice focuses on corporate finance transactions, including initial public offerings and mergers and acquisitions. He has experience in a wide range of general commercial and corporate finance transactions, including advising on legislation, compliance and regulatory work; corporate restructuring; advising clients under investigation by regulatory bodies such as the Securities and Futures Commission of Hong Kong; acquisitions and disposals of shares of private companies; sale and purchase of assets and businesses; due diligence; joint ventures; agency and distribution arrangements and general commercial advice; listing companies on the Hong Kong Stock Exchange (both Main Board and GEM Board); general corporate finance matters; and takeovers of listed companies.
Gordon was involved in advising the award winning deals Sisram Medical Ltd (HKSE: 1696) spin-off with over HK$1.1 billion Hong Kong IPO Listing, and GCL-Poly Energy Holdings Ltd. on its US$3.2 billion acquisition of Jiangsu Zhongneng Polysilicon Technology Development Co., Ltd.
Gordon also lectures regularly on a variety of subjects, including corporate acquisitions and the listing of companies on the Hong Kong Stock Exchange and the GEM Board.
Prior to joining Dentons, he was a partner with two international law firms and practiced in their Hong Kong offices.